Arne Dessen
11Patents
2h-index
11Co-inventors
51Inventor score
Filing activity: Jun 22, 1995 → Aug 20, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8815831B2 | Treatment of Acinetobacter with alginate oligomers and antibiotics | Human Necessities | 10 | Active |
| US5573792A | Method of growing fish or crustaceans at increased conversion, growth and survival rates | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7893038B2 | Oral immunostimulation of mammals birds and reptiles from (1-4) linked β-D-mannuronic acid | Human Necessities | 1 | Expired |
| US9018158B2 | Alginate oligomers for use in overcoming multidrug resistance in bacteria | Emerging Cross-Sectional Technologies | 1 | Active |
| US11413306B2 | Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tract | Human Necessities | 0 | Active |
| US11385174B2 | Method for the qualitative and quantitative detection of alginate oligomers in body fluids | Physics | 0 | Active |
| US10751363B2 | Use of aliginate oligomers and CFTR modulators in treatment of conditions associated with CFTR dysfunction | Human Necessities | 0 | Active |
| US7816340B2 | Oral immunostimulation of fish from (1-4) linked β-D-mannuronic acid | Human Necessities | 0 | Expired |
| US11992553B2 | Inhalable powder formulations of alginate oligomers | Human Necessities | 0 | Active |
| US11712448B2 | Use of alginate oligomers as blood anticoagulants | Human Necessities | 0 | Active |
| US9801901B2 | Alginate oligomers for use in overcoming multidrug resistance in bacteria | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.